Cerebral Macrovascular Disease Predicts Renal Failure in Type 2 Diabetes: In patients with Type 2 diabetes, silent cerebral infarction signaled an increased risk for progressive renal disease and renal failure, independent of microalbuminuria, according to a new study. During a mean 7.5 years of follow-up, patients with diabetes and silent …

Hypertension Identified as Number One Global Risk for Mortality: Hypertension is the leading global risk for mortality, responsible for 12.8% (7.5 million) of total deaths worldwide, according to a new report from the WHO. The report also identified hypertension as responsible for 3.8% of years of life lost due to …

Transition Therapeutics announces results of a Phase 2 study of TT-223 (GLP-1 Cpd + Gastrin) in Type 2 diabetes patients. The results show that beta-cells can possibly be generated and/or restored. After a 10 week trial the drug was stopped and 6 months later, the A1c had dropped by 1.13 points. 

The benefits of exercise can be greatly affected by the food we eat after it….

Researchers have found a low-carbohydrate diet helps people lose weight as effectively as a popular weight loss drug, and trumps the drug at lowering blood pressure….

Consistent with prior reports, but still surprising, diabetes does not worsen hospital mortality in critically ill patients, researchers say. In fact, diabetes is often associated with improved survival.…

Ten-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study shows positive results….

A study has compared two intensive therapies to lower blood glucose levels in patients with newly diagnosed Type 2 diabetes. The findings reveal the efficacy and safety of both insulin and triple oral therapy.

So-called silent strokes, visible on cerebral MRI scans, predict kidney failure in patients with Type 2 diabetes, researchers said.

An oral drug being developed by Novo Nordisk shows that it can boost the body’s own insulin production and may banish daily insulin injections for millions of people with diabetes…. The drug is about to be tested on 155 British patients as part of a trial that could transform treatment …